DNA Sequencing Market by Product & Services (Consumables, Instruments, Services), Technology (Next-Generation Sequencing, Sanger Sequencing, Third Generation DNA Sequencing), Workflow, Application - Global Forecast 2024-2030
The DNA Sequencing Market size was estimated at USD 60.39 billion in 2023 and expected to reach USD 71.98 billion in 2024, at a CAGR 19.51% to reach USD 210.34 billion by 2030.
DNA sequencing is the laboratory technique determining the sequence of nucleotides or bases in a single DNA molecule. DNA base sequence contains the encoded biological information that cells use to develop and function. DNA sequencing is used for various purposes, including diagnosis & disease treatment, medical research, and forensic analysis. Healthcare professionals can use sequencing to identify gene alterations or mutations of a specific disease condition. Rising cases of genetic disorders & cancer and growing demand for personalized medicine primarily boosting the research & development for DNA sequencing. Furthermore, technical limitations associated with DNA sequencing and the high cost of the sequencing platform limit the DNA sequencing market growth. In addition, complex data analysis & lack of standardized protocols lead to variability in the results of DNA sequencing. Moreover, the increasing adoption of DNA sequencing in clinical and research applications and the adoption of novel sequencing technologies, including next-generation sequencing, are expected to create lucrative opportunities for market growth. The rising investments in genomics research contribute to market growth.
Regional Insights
The Americas has a significant landscape in the DNA sequencing market owing to continuous technological developments by key players, high research and development investment, and availability of technologically advanced healthcare infrastructure, resulting in lucrative market growth in the forecasted period. Government initiatives in the U.S. and Canada supporting research in drug development and treatment of cancer have created significant market growth in North America. In Europe, the growing usage of DNA sequencing in laboratories, rising R&D, and increasing advancements in DNA sequencing technologies have created significant regional development. Asia-Pacific has a growing market in DNA sequencing due to strategic initiatives undertaken by international firms to expand their presence owing to the high customer base, which is expected to create market growth in the region.
Market Insights
- Market Dynamics
The market dynamics represent an ever-changing landscape of the DNA Sequencing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.- Market Drivers
- Increasing cases of genetic disorders across the world
- Increasing role of NGS in companion diagnostics and personalized medicines
- Growing usage of DNA sequencing across agrigenomics and forensics
- Market Restraints
- Technical limitations associated with DNA sequencing
- Market Opportunities
- Advancements and developments in DNA sequencing
- Rising investments in DNA sequencing and single-cell sequencing
- Market Challenges
- Issues associated with the accuracy, reliability, and ethical implications of DNA sequencing
- Market Segmentation Analysis
- Product & Services: Evolution across services with advances in bioinformatics and computational biology
- Technology: Growing popularity of next-generation sequencing (NGS) for ultra-high throughput
- Workflow: Rising preference for sequencing methods to meet accuracy requirements
- Application: Expanding application of DNA sequencing in clinical investigation for precise diagnosis and understanding of genetic disorders
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the DNA Sequencing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the DNA Sequencing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments- Ultima Genomics Launching High-end DNA Sequencers that can Read Genome for USD 100
Ultima Genomics introduced its cutting-edge UG 100 sequence, priced at USD 1.5 million. This advanced sequencing instrument possesses the capability to sequence up to 20,000 human genomes annually. Remarkably, the operational cost for reagents is impressively low, at just USD 1 per billion sequenced DNA bases. This efficiency equates to a mere USD 100 for the sequencing of a complete human genome, assuming the sequencing of each of the 3 billion base pairs in the human genome is performed 33 times, aligning with the industry's standard practice.
GBP 46.3 Million Funding Boost to Shine Light on Dark Genome
An MRC Human Genetics Unit from the University of Edinburgh has been granted a substantial GBP 46.3 million investment by the Medical Research Council (MRC) to bolster its work over the next five years, focusing on pioneering research into the 'dark genome.' This strategic funding marks a significant leap in genomics research in the UK to transform raw genomic data into actionable insights for tackling genetic conditions and improving patient outcomes.
BD, Hamilton Collaborate to Standardize Single-Cell Multiomics Experiments Using Robotics
Becton, Dickinson, and Company (BD) entered into a synergistic alliance with Hamilton to spearhead the development of automated solutions alongside robotics-compatible reagent kits. This collaboration aims to revolutionize large-scale single-cell multiomics experiments by significantly elevating standardization and minimizing human error. Through the fusion of BD's expertise in single-cell analysis and Hamilton's prowess in automation, the initiative unveils a series of BD Rhapsody Single-Cell Analysis Library Preparation Reagent Kits optimized for use on the Hamilton Microlab NGS STAR robotic liquid-handling platform.
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the DNA Sequencing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the DNA Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Abbott Laboratories, AbbVie Inc., Agilent Technologies, Inc., Azenta, Inc., Becton, Dickinson and Company, BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., BioChain Institute Inc., Charles River Laboratories International, Inc., Danaher Corporation, Dante Labs Inc., Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Genomics England, Genscript Biotech Corporation, Illumina, Inc., Johnson & Johnson Services, Inc., Konica Minolta, Inc., Laboratory Corporation of America Holdings, Macrogen Inc., Merck KGaA, Novartis AG, Novogene Co, Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., PerkinElmer, Inc., QIAGEN N.V., Sartorius AG, Shimadzu Corporation, SOPHiA GENETICS SA, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, and Veritas Genetics Inc. by LetsGetChecked.
Market Segmentation & Coverage
This research report categorizes the DNA Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product & Services
- Consumables
- Instruments
- Services
- Technology
- Next-Generation Sequencing
- Targeted Sequencing & Resequencing
- Whole Exome Sequencing
- Whole Genome Sequencing
- Sanger Sequencing
- Third Generation DNA Sequencing
- Nanopore Sequencing
- Single-Molecule Real-Time Sequencing
- Workflow
- Data Analysis
- Pre-Sequencing
- Sequencing
- Application
- Agrigenomics & Forensics
- Clinical Investigation
- Consumer Genomics
- HLA Typing or Immune System Monitoring
- Metagenomics, Epidemiology & Drug Development
- Oncology
- Reproductive Health
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
- Americas
- Next-Generation Sequencing
- Market Drivers
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing cases of genetic disorders across the world
- 5.1.1.2. Increasing role of NGS in companion diagnostics and personalized medicines
- 5.1.1.3. Growing usage of DNA sequencing across agrigenomics and forensics
- 5.1.2. Restraints
- 5.1.2.1. Technical limitations associated with DNA sequencing
- 5.1.3. Opportunities
- 5.1.3.1. Advancements and developments in DNA sequencing
- 5.1.3.2. Rising investments in DNA sequencing and single-cell sequencing
- 5.1.4. Challenges
- 5.1.4.1. Issues associated with the accuracy, reliability, and ethical implications of DNA sequencing
- 5.2. Market Segmentation Analysis
- 5.2.1. Product & Services: Evolution across services with advances in bioinformatics and computational biology
- 5.2.2. Technology: Growing popularity of next-generation sequencing (NGS) for ultra-high throughput
- 5.2.3. Workflow: Rising preference for sequencing methods to meet accuracy requirements
- 5.2.4. Application: Expanding application of DNA sequencing in clinical investigation for precise diagnosis and understanding of genetic disorders
- 5.3. Market Trend Analysis
- 5.3.1. Technological breakthroughs and growing focus on development of efficient diagnosis and treatments in the Americas
- 5.3.2. Increasing burden of rare and chronic diseases expanding the usage for DNA sequencing in APAC region
- 5.3.3. Increasing government investments and initiatives for personalized medications, creating the need for DNA sequencing in the EMEA
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework Analysis
- 6. DNA Sequencing Market, by Product & Services
- 6.1. Introduction
- 6.2. Consumables
- 6.3. Instruments
- 6.4. Services
- 7. DNA Sequencing Market, by Technology
- 7.1. Introduction
- 7.2. Next-Generation Sequencing
- 7.3. Sanger Sequencing
- 7.4. Third Generation DNA Sequencing
- 8. DNA Sequencing Market, by Workflow
- 8.1. Introduction
- 8.2. Data Analysis
- 8.3. Pre-Sequencing
- 8.4. Sequencing
- 9. DNA Sequencing Market, by Application
- 9.1. Introduction
- 9.2. Agrigenomics & Forensics
- 9.3. Clinical Investigation
- 9.4. Consumer Genomics
- 9.5. HLA Typing or Immune System Monitoring
- 9.6. Metagenomics, Epidemiology & Drug Development
- 9.7. Oncology
- 9.8. Reproductive Health
- 10. Americas DNA Sequencing Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific DNA Sequencing Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa DNA Sequencing Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. Market Share Analysis, 2023
- 13.2. FPNV Positioning Matrix, 2023
- 13.3. Competitive Scenario Analysis
- 13.3.1. Ultima Genomics Launching High-end DNA Sequencers that can Read Genome for USD 100
- 13.3.2. GBP 46.3 Million Funding Boost to Shine Light on Dark Genome
- 13.3.3. BD, Hamilton Collaborate to Standardize Single-Cell Multiomics Experiments Using Robotics
- 13.3.4. Oxford Nanopore Announces Performance in Simplex Single Molecule Accuracy to Provide Comprehensive Genomic Data for Diverse Customer Types
- 13.3.5. Element Biosciences Inc. and Agilent Technologies Expand Partnership to Expand Product Portfolio
- 13.3.6. Alliance Hopes to Automate Nanopore Library Preparation to Revolutionize the DNA Sequencing
- 13.3.7. Tecan and Oxford Nanopore partnered for Long Fragment DNA Sequencing
- 13.3.8. UPS Healthcare & Oxford Nanopore partner to deliver DNA sequencing tech across APAC
- 13.3.9. NIH Software Assembles Complete Genome Sequences On-demand
- 13.3.10. Eurofins Genomics US Launches Express Oxford Nanopore Sequencing Service with Same-Day Results
- 13.3.11. QIAGEN Digital Insights launched ultra-fast NGS Analysis Able To Process a Whole Genome In 25 minutes For A USD 1 Cloud Computing Costs
- 13.3.12. UK Set to Boost Genomics Expertise Through a Landmark Partnership with Thailand
- 13.3.13. Complete Genomics Launches Full Sequencing Platforms at Biotech Showcase 2023
- 13.3.14. Illumina Expands Collaboration with Janssen to Advance Molecular Residual Disease Cancer Test
- 13.3.15. Agilent Acquires Avida Biomed, Boosting Next-generation Sequencing for Cancer Research
- 13.3.16. Element Biosciences Unveils New DNA Sequencing Instrument, Chemistry
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.2. Key Product Portfolio
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook